Hoyos Rocio Martin
SEC insider (Form 3/4/5 filer). CIK 0002107515. Chief Strategy Officer at Atrium Therapeutics, Inc. (RNA). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in SAN DIEGO, CA.
Companies Hoyos Rocio Martin has filed insider reports for
- Atrium Therapeutics, Inc. (RNA): Officer, Chief Strategy Officer
Hoyos Rocio Martin
CIK: 0002107515
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNA
Atrium Therapeutics, Inc.
Officer